This table shows the list known insiders, and is generated automatically from filings disclosed to the SEC. In addition to the names, most recent title, and director, officer, or 10% owner designation, we provide the latest disclosed holdings.
| Name | Shares | Options |
|---|---|---|
| Greenfield Andrew J | 0 | 2,868 |
| MINOGUE MICHAEL R | 0 | 50,000 |
| Rolle Myron L | 0 | 0 |
| Trapp Todd A | 0 | 3,737 |
| Weber David M | 0 | 0 |
| MINOGUE MICHAEL R - E | 0 | 0 |
| TERMEER HENRI A by Genzyme Corporation | 0 | 0 |
| Bowen Robert | 0 | 7,500 |
| Plano Matthew T. | 0 | 0 |
| Johnson Paula A | 0 | 0 |
| SUTTER MARTIN P By Essex Woodland Health Ventures, VI, LP | 0 | 0 |
| MINOGUE MICHAEL R - C | 0 | 0 |
| Bowen Robert By 401(k) Plan | 0 | 0 |
| TERMEER HENRI A By Genzyme Corporation | 0 | 0 |
| SUTTER MARTIN P Essex Woodlands Health Ventures Fund VII, LP | 0 | 0 |
| Van Gorder Chris | 0 | 0 |
| Howley Michael G | 0 | 2,206 |
| MINOGUE MICHAEL R - F | 0 | 0 |
| TERMEER HENRI A | 0 | 0 |
| AUSTEN W GERALD | 0 | 0 |
| LATAIF LOUIS E | 0 | 0 |
| Sutherby Daniel J | 0 | 10,000 |
| Fitch Patricia A. | 0 | 50,000 |
| Began Marc A | 0 | 0 |
| SUTTER MARTIN P | 0 | 0 |
| BOLT WILLIAM J | 0 | 0 |
| McLeod Ian | 0 | 0 |
| SUTTER MARTIN P Essex Woodlands Health Ventures Fund VI, LP | 0 | 0 |
| GOTTLIEB DAVID | 0 | 8,000 |
| TERMEER HENRI A by Genzyme Corporation | 0 | 0 |
| DOLLENS RONALD W | 0 | 12,000 |
| Macdonald Christopher D | 0 | 5,000 |
| PUHY DOROTHY E | 0 | 0 |
| RIVET JEANNINE M | 0 | 0 |
| TOMSICEK MICHAEL JOHN | 0 | 0 |
| AUSTEN W GERALD Footnote | 0 | 0 |
| MINOGUE MICHAEL R - C | 0 | 0 |
| MINOGUE MICHAEL R - B | 0 | 0 |
| O CONNELL DESMOND JR | 0 | 12,000 |
| ABIOMED INC | 0 | 0 |
| 0 | 0 | |
| THOMAS PAUL | 0 | 0 |
| ROSE ERIC A MD | 0 | 0 |
| MINOGUE MICHAEL R - A | 0 | 0 |
| Flaherty Sheila Marie | 0 | 0 |
| Jimenez Javier | 0 | 0 |
| Benali Karim | 0 | 4,000 |
| Farra Robert | 0 | 5,000 |
| KUNG ROBERT T V | 0 | 4,000 |
| McEvoy Stephen C | 0 | 30,000 |
While Insider sales are normal part of tax harvesting and is part of compensation of executives - A large number of transactions would indicate that the management isnt convinced that the price will go up and hence reducing their holding. This would be a possible indicator or fall in price
| Name | Shares | Price | Date |
|---|
Insider buys arent usual, since it indicates a high conviction by the management that they believe the price will go up eventually. Usually a good sign that investors should consider this as a factor to purchase a stock, especially if the current SP is lower than the price the management bought these at. The table below doesnt include any Stock Options or RSUs. They're just open market purchases by the insiders.
| Name | Shares | Price | Date |
|---|